Not Yet RecruitingNot Applicable

Study on Effect of Papworth Technique in Anemic Asthmatic Pediatrics

40 participantsStarted 2024-12-20

Plain-language summary

As asthma is chronic condition which interferes with quality of life and exercise tolerance, so it is important to find out cost-effective alternative for the management of asthma due to increased prevalence and rising health care cost as well . Therefore, to provide comprehensive asthma treatment, it is necessary to rule out and address the factor affecting quality of life and exercise tolerance. Asthmatics require stepwise approach which contains assessment treatment planning and review of response. Along with this modification of risk factors, controller therapy is adjusted accordingly. But this is inadequate for asthma management as pharmacological management has some side effects. So, in addition to medical care, Papworth method provides good adjuvant to control asthma symptoms. Asthma subjects require comprehensive approach to deal with these hyperinflation and hyperventilation which are common manifestations of asthma

Who can participate

Age range

12 Years – 18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

. 40 patients from both genders.
. Participants between the age 12 and 18 years
. Oriented, medically stable and taking their medical treatment
. Mild and moderate asthma
. All patients are diagnosed as iron deficiency anemia
. Body mass index between 18.5 -24.9

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Haemoglobin level

Timeframe: AFTER 12 WEEKS

Asthma-related Quality of life questionnaire (AQLQ)

Timeframe: AFTER 12 WEEKS

Six-minute walk test.

Timeframe: AFTER 12 WEEKS

Oxygen saturation

Timeframe: AFTER 12 WEEKS

Respiratory rate

Timeframe: AFTER 12 WEEKS

Trial details

NCT IDNCT06750354

SponsorCairo University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-01-15

Contact for this trial

alaa mohamed naguib lecturer, lecturer

01092224967 Alaanaguib91@cu.edu.eg

View on ClinicalTrials.gov More Anaemia trials

Plain-language summary

Who can participate

Age range

12 Years – 18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

. 40 patients from both genders.
. Participants between the age 12 and 18 years
. Oriented, medically stable and taking their medical treatment
. Mild and moderate asthma
. All patients are diagnosed as iron deficiency anemia
. Body mass index between 18.5 -24.9